[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease].

Dirk Woitalla; Rejko Krüger; Stefan Lorenzl; Thomas Müller; Guenther Oelwein; Alexander Storch; Martin Wolz; Ullrich Wüllner

doi:10.1055/a-1149-9308

[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease].

Dirk Woitalla, Rejko Krüger, Stefan Lorenzl (Co-Autor/-in), Thomas Müller, Guenther Oelwein, Alexander Storch, Martin Wolz, Ullrich Wüllner

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Deutsch
Seiten (von - bis)	620-633
Fachzeitschrift	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
Jahrgang	88
Ausgabenummer	9
DOIs	https://doi.org/10.1055/a-1149-9308
Publikationsstatus	Veröffentlicht - 2020

Zugriff auf Dokument

10.1055/a-1149-9308

Dieses zitieren

Woitalla, D., Krüger, R., Lorenzl, S., Müller, T., Oelwein, G., Storch, A., Wolz, M., & Wüllner, U. (2020). [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE , 88(9), 620-633. https://doi.org/10.1055/a-1149-9308

Woitalla, Dirk ; Krüger, Rejko ; Lorenzl, Stefan et al. / [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease]. in: FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE 2020 ; Jahrgang 88, Nr. 9. S. 620-633.

@article{723b0bc78fbc4dd9a2e64eb9695fff4f,

title = "[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson{"}s disease].",

keywords = "CATECHOL-O-METHYLTRANSFERASE, DOUBLE-BLIND, NATURAL-HISTORY, ALPHA-SYNUCLEIN, LEVODOPA, DOPAMINE, ENTACAPONE, TOLCAPONE, SELEGILINE, TRIAL",

author = "Dirk Woitalla and Rejko Kr{\"u}ger and Stefan Lorenzl and Thomas M{\"u}ller and Guenther Oelwein and Alexander Storch and Martin Wolz and Ullrich W{\"u}llner",

year = "2020",

doi = "10.1055/a-1149-9308",

language = "Deutsch",

volume = "88",

pages = "620--633",

journal = "FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE ",

issn = "0720-4299",

number = "9",

}

Woitalla, D, Krüger, R, Lorenzl, S, Müller, T, Oelwein, G, Storch, A, Wolz, M & Wüllner, U 2020, '[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease].', FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE , Jg. 88, Nr. 9, S. 620-633. https://doi.org/10.1055/a-1149-9308

[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease]. / Woitalla, Dirk; Krüger, Rejko; Lorenzl, Stefan (Co-Autor/-in) et al.
in: FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE , Jahrgang 88, Nr. 9, 2020, S. 620-633.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease].

AU - Woitalla, Dirk

AU - Krüger, Rejko

AU - Lorenzl, Stefan

AU - Müller, Thomas

AU - Oelwein, Guenther

AU - Storch, Alexander

AU - Wolz, Martin

AU - Wüllner, Ullrich

PY - 2020

Y1 - 2020

KW - CATECHOL-O-METHYLTRANSFERASE

KW - DOUBLE-BLIND

KW - NATURAL-HISTORY

KW - ALPHA-SYNUCLEIN

KW - LEVODOPA

KW - DOPAMINE

KW - ENTACAPONE

KW - TOLCAPONE

KW - SELEGILINE

KW - TRIAL

U2 - 10.1055/a-1149-9308

DO - 10.1055/a-1149-9308

M3 - Originalarbeit

C2 - 32588409

SN - 0720-4299

VL - 88

SP - 620

EP - 633

JO - FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE

JF - FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE

IS - 9

ER -

Woitalla D, Krüger R, Lorenzl S, Müller T, Oelwein G, Storch A et al. [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson"s disease]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE . 2020;88(9):620-633. doi: 10.1055/a-1149-9308